Close

Immunomedics (IMMU) Reports In-Line Q4 Loss of 13c/Share

August 19, 2015 4:01 PM EDT

Immunomedics (NASDAQ: IMMU) reported Q4 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $2.4 million versus the consensus estimate of $1.13 million.

For earnings history and earnings-related data on Immunomedics (IMMU) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings